36th Annual Chemotherapy Foundation Symposium (CFS)
In-Person Event
Nov 07 - 09, 2018
New York, New York, USA
OVERVIEW
36th Annual Chemotherapy Foundation Symposium (CFS) is organized by Physicians Education Resource, LLC (PER) and will be held from Nov 07 - 09, 2018 at New York Marriott Marquis, New York, United States of America.
The target audience for this medical event is directed toward oncologists, hematologists, nurses, nurse practitioners, and pharmacists interested in the treatment/management of patients with cancer. Radiotherapists, immunologists, fellows, physician assistants, researchers, case managers, and other healthcare professionals interested in the treatment of cancer are also invited to attend. This CME Conference has been approved for a maximum of 26.75 AMA PRA Category 1 Credits.
Conference Overview :
Rapid changes continue to occur in the management of solid and hematologic malignancies. Just this past year, practice-changing diagnostic, therapeutic, and supportive care strategies have entered clinical practice, and many more are poised to enter the field. Improved outcomes are achievable across multiple lines of care with the application of optimized testing approaches, locoregional and systemic therapies, targeted therapies, immunotherapies, and multimodal strategies. Critical knowledge and competency gaps among practitioners must be addressed to ensure that these approaches are effectively and safely integrated into practice. Each year, the Chemotherapy Foundation Symposium (CFS), brings together more than 2000 healthcare professionals for 3 days, with the aim of promoting the delivery of evidence-based, state-of-the-art cancer care for routine and the most challenging clinical scenarios. At the 36th Annual CFS, our internationally renowned faculty will provide expert insights on the latest developments in cancer therapeutics, offering oncology practitioners an unparalleled opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize care and outcomes for their patients with cancer.
Benefits of Attending :
• Incorporate the latest clinical data into your practice
• Challenge the experts with your most difficult cases
• Network with the top minds in oncology
• 100 Experts. 25 Tumor Types. 3 Days. 1 Meeting.
Learning Objectives :
Upon completion of this activity, participants should be better prepared to:
• Determine the most appropriate testing strategies to identify molecular marker and treatment targets while stratifying risk to inform clinical decision-making in cancer management
• Describe key practice-changing clinical trial results that inform appropriate diagnostic and treatment approaches for patients with hematologic malignancies and solid tumors
• Identify evidence-based immunotherapeutic, chemotherapeutic, and targeted treatment strategies to optimize clinical outcomes
• Delineate implementation strategies for multidisciplinary teams to anticipate and proactively manage treatment-related toxicities
• Review and apply practice-changing evidence presented at major conferences and apply these findings to optimize the care of patients with cancer
Additional details will be posted as soon as they are available.
The target audience for this medical event is directed toward oncologists, hematologists, nurses, nurse practitioners, and pharmacists interested in the treatment/management of patients with cancer. Radiotherapists, immunologists, fellows, physician assistants, researchers, case managers, and other healthcare professionals interested in the treatment of cancer are also invited to attend. This CME Conference has been approved for a maximum of 26.75 AMA PRA Category 1 Credits.
Conference Overview :
Rapid changes continue to occur in the management of solid and hematologic malignancies. Just this past year, practice-changing diagnostic, therapeutic, and supportive care strategies have entered clinical practice, and many more are poised to enter the field. Improved outcomes are achievable across multiple lines of care with the application of optimized testing approaches, locoregional and systemic therapies, targeted therapies, immunotherapies, and multimodal strategies. Critical knowledge and competency gaps among practitioners must be addressed to ensure that these approaches are effectively and safely integrated into practice. Each year, the Chemotherapy Foundation Symposium (CFS), brings together more than 2000 healthcare professionals for 3 days, with the aim of promoting the delivery of evidence-based, state-of-the-art cancer care for routine and the most challenging clinical scenarios. At the 36th Annual CFS, our internationally renowned faculty will provide expert insights on the latest developments in cancer therapeutics, offering oncology practitioners an unparalleled opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize care and outcomes for their patients with cancer.
Benefits of Attending :
• Incorporate the latest clinical data into your practice
• Challenge the experts with your most difficult cases
• Network with the top minds in oncology
• 100 Experts. 25 Tumor Types. 3 Days. 1 Meeting.
Learning Objectives :
Upon completion of this activity, participants should be better prepared to:
• Determine the most appropriate testing strategies to identify molecular marker and treatment targets while stratifying risk to inform clinical decision-making in cancer management
• Describe key practice-changing clinical trial results that inform appropriate diagnostic and treatment approaches for patients with hematologic malignancies and solid tumors
• Identify evidence-based immunotherapeutic, chemotherapeutic, and targeted treatment strategies to optimize clinical outcomes
• Delineate implementation strategies for multidisciplinary teams to anticipate and proactively manage treatment-related toxicities
• Review and apply practice-changing evidence presented at major conferences and apply these findings to optimize the care of patients with cancer
Additional details will be posted as soon as they are available.
KEY DATES
07 Nov, 2018
Event Start Date
09 Nov, 2018
Event End Date
SPECIALITIES
OncologyHaematologySUGGESTED HOTELS
CONFERENCE VENUE
New York Marriott MarquisRELATED CONFERENCES & LIVE WEBINARS
Quick Links